Back to Search Start Over

Bacterial Vaginosis--Vaginal Polymicrobial Biofilms and Dysbiosis.

Authors :
Swidsinski, Sonja
Moll, Wiltrud Maria
Swidsinski, Alexander
Source :
Deutsches Ärzteblatt International; 5/19/2023, Vol. 120 Issue 20, p347-354, 13p
Publication Year :
2023

Abstract

Background: Bacterial vaginosis (BV) is the most common genital disease worldwide in women of sexually active age, with a prevalence of 23-9%. Its traditional definition as dysbiosis, i.e., a disruption of the normal balance of the vaginal microbiota, with a massive increase of facultative and obligate anaerobic bacteria (mainly Gardnerella spp.) and a loss of lactobacilli, accurately describes the change in the vaginal microbiota, but does not explain the underlying pathophysiology. Methods: This review is based on information in pertinent articles retrieved by a selective literature search and on the authors' own research findings. Results: Fluorescent in situ hybridization (FISH) has revealed Gardnerella spp.--dominated polymicrobial vaginal biofilm as a cause of ascending gynecologic and pregnancy-related infections, preterm birth, and infertility in patients with BV. The biofilm-induced disturbance of epithelial homeostasis favors co-infection with pathogens of sexually transmitted infection (STI). Standard antibiotic therapy is ineffective against biofilms, and there is thus a recurrence rate above 50%. The characteristic biofilm can be followed as a diagnostic marker and is considered evidence of sexual transmission when heterosexual couples and ejaculate samples are examined. FISH studies have shown that, in addition to biofilm-related vaginosis, there are other dysbiotic changes in the vaginal microbiota that have not yet been characterized in detail. It is therefore justified to speak of a "bacterial vaginosis syndrome." Conclusion: The simplistic view of BV as dysbiosis, characterizable by microscopic reference methods, has so far led to inadequate therapeutic success. An evaluation of molecular genetic testing methods that would be suitable for routine use and the development of therapeutic agents that are effective against biofilms are urgently needed if the "bacterial vaginosis syndrome" is to be effectively treated. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
18660452
Volume :
120
Issue :
20
Database :
Complementary Index
Journal :
Deutsches Ă„rzteblatt International
Publication Type :
Academic Journal
Accession number :
166734786
Full Text :
https://doi.org/10.3238/arztebl.m2023.0090